Table of Contents
<< Previous Issue | Feb 2011 (Vol: 2011, Issue: 2) | Next Issue >> |
- Section: Cartoons
-
Once-a-week
- Section: Distribution & Marketing
-
Allergan and MAP Pharmaceuticals Sign Co-Promotion Deal for Acute Migraine Treatment
- Section: Licensing
-
Astellas Licenses Regional Rights to Optimer Pharmaceuticals’ Antibiotic for Clostridium Difficile Infection
-
Progenics Licenses Relistor® to Salix Outside of Japan
- Section: Mergers & Acquisitions
-
Novartis Advances its Capabilities in Personalised Medicine with Genoptix Acquisition
-
Amgen Signs Billion-Dollar Deal to Acquire BioVex for its Oncolytic Vaccine
-
Alexion Pharmaceuticals Boosts its Rare Disease Pipeline with Taligen Acquisition
-
Valeant to Acquire PharmaSwiss and Expand its Presence in Central and Eastern Europe
-
AdventRx Acquires SynthRx for Late-Stage Sickle Cell Disease Drug
- Section: Opinion & Analysis
-
ANNUAL REVIEW: Deal Making in 2010
- Section: Research & Development
-
Anacor and Medicis in US$160 M Acne Research Pact